Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Feb
25
2021
Arthrex’s Reply – Removing Tenure Doesn’t Solve the Problem and Defies Congressional Intent Foley & Lardner LLP
May
3
2021
Sealing Judicial Records or How I Learned to Stop Consenting and Protect Trade Secrets Foley & Lardner LLP
Apr
14
2015
Stricter Standing For Inter Partes Review? Foley & Lardner LLP
Feb
18
2022
Use of the “Hecho en México”® (Made in Mexico) Trademark and Logo Foley & Lardner LLP
Sep
20
2017
Celgene Notches Rare Win On PTAB Request For Rehearing Foley & Lardner LLP
Jun
15
2015
Federal Circuit Hold Sequenom Diagnostic Method Patent Invalid Under 101 Foley & Lardner LLP
Sep
25
2017
USPTO Update on Patent-Eligibility for Life Science Inventions Foley & Lardner LLP
Jul
17
2015
Federal Circuit Upholds Broadest Reasonable Interpretation in Inter Partes Review Foley & Lardner LLP
Jul
19
2022
A Third Surge in Innovation and Patents on Hydrogen Fuel Cell Vehicles Foley & Lardner LLP
Aug
5
2015
Does Spike In IPR Settlements Signify Petitioner Success? Foley & Lardner LLP
Oct
4
2022
USPTO Extends Patents 4 Patients Program Foley & Lardner LLP
Sep
10
2015
Clinical Trials As Prior Art: PTAB Denies Bass IPR Petition With Only A "Hope" of Efficacy Foley & Lardner LLP
Mar
20
2018
An Economic Test For Patent Eligibility? Foley & Lardner LLP
Sep
28
2015
PTAB Refuses To Sanction Kyle Bass Foley & Lardner LLP
Apr
24
2018
Supreme Court Upholds Constitutionality Of IPRs In Oil States Foley & Lardner LLP
Feb
1
2023
EPO and IEA Release Hydrogen Patent Report Showing Automotive Sector Plays a Key Role in Innovation Foley & Lardner LLP
Oct
27
2015
Morsa II: Admissions Enable Prior Art Foley & Lardner LLP
Mar
27
2023
IP Lawyer vs. ChatGPT: Top 10 Legal Issues of Using Generative AI at Work Foley & Lardner LLP
Nov
19
2015
Federal Circuit Interprets Two Important Infringement Provisions Foley & Lardner LLP
Aug
16
2018
Restoring America’s Leadership in Innovation Act of 2018 Foley & Lardner LLP
Dec
3
2015
Federal Circuit Confirms Constitutionality of IPR Proceedings in MCM Portfolio v. Hewlett-Packard Foley & Lardner LLP
Dec
8
2015
Judge Lourie (Federal Circuit) Suggests Jepson Claims For Patent Eligibility Foley & Lardner LLP
Oct
11
2018
Federal Circuit Finds Detection Claims Invalid Under 101 Foley & Lardner LLP
Nov
13
2018
Not-Quite Prior Art Supports Obviousness Of Copaxone Patents In IPR Proceedings Foley & Lardner LLP
Jun
27
2023
Protecting Innovations in SaMD & Biomedical Applications Foley & Lardner LLP
Aug
7
2023
Trends In Orange Book and Biologic PTAB Trials Foley & Lardner LLP
Oct
20
2023
Prosecution Laches—Another Arrow In The Quiver For Challenging Patents Foley & Lardner LLP
Jun
28
2019
Buyer Beware: Post-Facto Mergers a New Potential IPR Killer Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins